Why the study?
Both Canx-deficient and Fabp5-deficient mice show resistance to EAE induction, but the role of Fabp5/Canx interactions in EAE pathogenesis and blood-brain barrier permeability remained to be evaluated.
The Fabp5/calnexin complex is essential for immune cell transmigration across the blood-brain barrier and subsequent EAE pathogenesis, highlighting a potential therapeutic target for inflammatory demyelinating diseases.
Highlights Canx-Fabp5 as potential BBB regulator in neuroinflammation; leaves open translation to MS therapies.
We previously showed that calnexin (Canx)-deficient mice are desensitized to experimental autoimmune encephalomyelitis (EAE) induction, a model that is frequently used to study inflammatory demyelinating diseases, due to increased resistance of the blood-brain barrier to immune cell transmigration. We also discovered that Fabp5, an abundant cytoplasmic lipid-binding protein found in brain endothelial cells, makes protein-protein contact with the cytoplasmic C-tail domain of Canx. Remarkably, both Canx-deficient and Fabp5-deficient mice commonly manifest resistance to EAE induction. Here, we evaluated the importance of Fabp5/Canx interactions on EAE pathogenesis and on the patency of a model blood-brain barrier to T-cell transcellular migration. The results demonstrate that formation of a complex comprised of Fabp5 and the C-tail domain of Canx dictates the permeability of the model blood-brain barrier to immune cells and is also a prerequisite for EAE pathogenesis.
No takes yet. Share an insight, caveat, or question.
Paškevičius et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: